Tschanter, P. and Krug, U. and Fueller, M. and Klein, M. and Goellner, S. and Rohde, C. and Roellig, C. and Thiede, C. and Lilly, M. A. and Haack, B. and Koschmieder, A. and Stelljes, M. and Dugas, M. and Koschmieder, S. and Gerss, J. and Butterfass-Bahloul, T. and Wagner, R. and Eveslage, M. and Thiem, U. and Krause, S. W. and Kaiser, U. and Kunzmann, V and Steffen, B. and Noppeney, R. and Herr, W. and Baldus, C. D. and Schmitz, N. and Goetze, K. and Reichle, A. and Kaufmann, M. and Neubauer, A. and Schaefer-Eckart, K. and Haenel, M. and Peceny, R. and Frickhofen, N. and Kiehl, M. and Giagounidis, A. and Goerner, M. and Repp, R. and Link, H. and Kiani, A. and Naumann, R. and Bruemmendorf, T. H. and Serve, H. and Ehninger, G. and Berdel, W. E. and Mueller-Tidow, C.
(2015)
DNMT3A mutations in exon 23 are associated with improved survival in AML patients treated with Azacytidine plus standard chemotherapy.
Oncology Research and Treatment, 38 (Suppl5).
p. 122.
ISSN 2296-5270, 2296-5262
Full text not available from this repository.
Actions (login required)
 |
View Item |
